Get the Stockscreener App
25.68
6.73%
1.62
After Hours:
25.68
Biolife Solutions Inc stock is traded at $25.68, with a volume of 709.83K.
It is up +6.73% in the last 24 hours and up +16.99% over the past month.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
See More
Previous Close:
$24.06
Open:
$24.29
24h Volume:
709.83K
Relative Volume:
1.27
Market Cap:
$1.23B
Revenue:
$151.91M
Net Income/Loss:
$-46.03M
P/E Ratio:
-25.43
EPS:
-1.01
Net Cash Flow:
$5.65M
1W Performance:
+21.76%
1M Performance:
+16.99%
6M Performance:
-5.38%
1Y Performance:
-3.17%
1-Day Range:
$24.04
$25.73
1-Week Range:
$20.27
$25.73
52-Week Range:
$19.10
$29.55
Biolife Solutions Inc Stock (BLFS) Company Profile
Name
Biolife Solutions Inc
Sector
Industry
Phone
(425) 401-1400
Address
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
25.68 | 1.15B | 151.91M | -46.03M | 5.65M | -1.01 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-25 | Resumed | Stephens | Overweight |
| Sep-30-24 | Initiated | H.C. Wainwright | Buy |
| Apr-04-24 | Initiated | Jefferies | Buy |
| Jul-11-23 | Initiated | Craig Hallum | Buy |
| Apr-25-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-19-21 | Initiated | B. Riley Securities | Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| May-14-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-23-21 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-22-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-18-20 | Initiated | Cowen | Outperform |
| Aug-11-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-08-20 | Reiterated | Maxim Group | Buy |
| Feb-24-20 | Initiated | Lake Street | Buy |
| Feb-19-20 | Initiated | The Benchmark Company | Buy |
| Feb-06-20 | Resumed | B. Riley FBR | Buy |
| Jan-08-20 | Initiated | Stephens | Overweight |
| Nov-21-19 | Initiated | Oppenheimer | Outperform |
| Jul-22-19 | Initiated | H.C. Wainwright | Buy |
| Nov-10-17 | Reiterated | Maxim Group | Buy |
| Sep-19-17 | Reiterated | Maxim Group | Buy |
| Jul-05-17 | Upgrade | Janney | Neutral → Buy |
| Mar-10-17 | Reiterated | Maxim Group | Buy |
| Jan-19-17 | Initiated | Maxim Group | Buy |
View All
Biolife Solutions Inc Stock (BLFS) Latest News
Casdin Partners sells BioLife Solutions NASDAQ:BLFS shares for $11.3m - Investing.com
BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why - MSN
BioLife (BLFS) Is Up 16.1% After Raising 2025 Guidance and Reporting Strong Q2 Results - simplywall.st
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know - sharewise.com
BioLife Solutions Reports Strong Q2 Growth Amid Challenges - TipRanks
BioLife Solutions, Inc. (NASDAQ:BLFS) Q2 2025 Earnings Call Transcript - Insider Monkey
Analysts Weigh In on Green Thumb Industries, Doximity, and BioLife Solutions - AInvest
BioLife Solutions raises 2025 revenue guidance to $100M–$103M as cell processing momentum accelerates - MSN
BioLife Solutions Reports Strong Q2 2025 Growth - TipRanks
What You Can Learn From BioLife Solutions, Inc.'s (NASDAQ:BLFS) P/S - 富途牛牛
BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025 - goSkagit
Regression analysis insights on BioLife Solutions Inc. performanceAI Intraday Market Movement Prediction Tool - Newser
Will BioLife Solutions Inc. rebound enough to break evenWeekly Stock Market Strategy Summary - Newser
BioLife Solutions (NASDAQ:BLFS) Receives “Buy” Rating from HC Wainwright - Defense World
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2 - MSN
A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $30 to $32 - 富途牛牛
BioLife Solutions Receives Buy Rating from Northland Securities, Price Target at $31.00 - AInvest
BioLife Solutions (BLFS) Is Up 9.0% After Raising 2025 Revenue Outlook Has The Bull Case Changed? - simplywall.st
BioLife Solutions Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Is BioLife Solutions (NASDAQ:BLFS) A Risky Investment? - simplywall.st
BioLife Solutions (NASDAQ:BLFS) Trading 12.5% Higher on Analyst Upgrade - Defense World
How to use a screener to detect BioLife Solutions Inc. breakoutsDaily Trade Monitor with Pattern Alerts - Newser
Can you recover from losses in BioLife Solutions Inc.Smart Trade Forecast Based on Neural Logic - Newser
BioLife Solutions 2025 Q2 Earnings Loss Narrows 23.6% as Revenue Rises 28.9% - AInvest
BioLife Solutions Raises 2025 Revenue Guidance to $100M-$103M on Cell Processing Momentum - AInvest
BioLife Solutions: HC Wainwright Raises PT to $32, Maintains Buy Rating - AInvest
Earnings call transcript: BioLife Solutions Q2 2025 sees EPS miss, raises revenue guidance - Investing.com Nigeria
BioLife Solutions Inc reports results for the quarter ended June 30Earnings Summary - TradingView
BioLife Solutions: Strong Performance and Growth Potential with Buy Rating - TipRanks
BioLife Solutions: Strategic Reinvention and Growth in the Biopreservation Sector - AInvest
BioLife Solutions Updates 2025 Revenue Guidance to $100-103mln, Reflecting 22-25% YoY Growth - AInvest
BioLife Solutions earnings missed by $0.30, revenue topped estimates - Investing.com Canada
BioLife Solutions Q2 revenue up 28% YoY to $23mln, raises FY23 guidance. - AInvest
BioLife Solutions Reports Second Quarter 2025 Financial Results - TradingView
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $25.4M, vs. FactSet Est of $23.7M - MarketScreener
Market reaction to BioLife Solutions Inc.’s recent newsReliable Setup Screener with Low Risk - Newser
BioLife Solutions, Inc. (NASDAQ:BLFS) Receives Consensus Rating of “Buy” from Analysts - Defense World
BioLife Solutions BLFS 2025Q2 Earnings Preview Upside Anticipated on Robust Revenue Growth - AInvest
Is BioLife Solutions Inc. the Top Chart Pick This WeekEarly Breakout Entry Point Notifications Sent - beatles.ru
BioLife Solutions Inc. Approaches Psychological Resistance LevelDay Trading Signals With High Precision Reviewed - metal.it
How volatile is BioLife Solutions Inc. stock compared to the marketUnlock daily market insights for better trades - Jammu Links News
What makes BioLife Solutions Inc. stock price move sharplyExplosive earnings growth - Jammu Links News
Is BioLife Solutions Inc. stock overvalued or undervaluedMaximize portfolio growth with strategic plans - Jammu Links News
How many analysts rate BioLife Solutions Inc. as a “Buy”Build wealth with long-term growth strategies - Jammu Links News
What catalysts could drive BioLife Solutions Inc. stock higher in 2025Rapid profit acceleration - Jammu Links News
What are BioLife Solutions Inc. company’s key revenue driversFree Risk Assessment Services - Jammu Links News
Reversal indicators forming on BioLife Solutions Inc. stockReversal Pattern Insights with Entry Tips - Newser
BioLife Solutions Inc. Stock Analysis and ForecastBreakneck growth rates - Jammu Links News
Contrasting GlucoTrack (NASDAQ:GCTK) & BioLife Solutions (NASDAQ:BLFS) - Defense World
Candlestick signals on BioLife Solutions Inc. stock todayTechnical Screener for High Growth Stocks - Newser
Why is BioLife Solutions Inc. stock attracting strong analyst attentionInvest in stocks with strong fundamentals - Jammu Links News
Biolife Solutions Inc Stock (BLFS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):